Cyndeo Wealth Partners’s ResMed RMD Stock Holding History

Cyndeo Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,053	Closed	-$288K	–	500
2025 Q3	$288K	Buy	+1,053	New	+$288K	0.02%	398

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cyndeo Wealth Partners's RMD Position: Q4 2025 in Review

Cyndeo Wealth Partners sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,053 shares — an estimated $288K sold.

Cyndeo Wealth Partners first reported a position in RMD in Q3 2025 and held it in 1 quarter. The position peaked at $288K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Cyndeo Wealth Partners reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Cyndeo Wealth Partners sold 1,053 ResMed shares in Q4 2025, an estimated $288K.
Cyndeo Wealth Partners first reported a position in ResMed in Q3 2025 and held it in 1 quarter.
Cyndeo Wealth Partners's ResMed position peaked at $288K in Q3 2025.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Cyndeo Wealth Partners's 13F filing for Q4 2025, filed 7 Jan 2026.